WSJ -- Microsoft Corp. co-founder Bill Gates has made a small investment in a pharmaceutical-software maker, in a bid to reinvigorate a quest to use computers to revolutionize drug development.
WSJ -- Microsoft Corp. co-founder Bill Gates has made a small investment in a pharmaceutical-software maker, in a bid to reinvigorate a quest to use computers to revolutionize drug development.
